135 related articles for article (PubMed ID: 35044623)
1. The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson's Disease.
Zapała B; Stefura T; Piwowar M; Czekalska S; Zawada M; Hadasik M; Solnica B; Rudzińska-Bar M
J Mol Neurosci; 2022 Apr; 72(4):812-819. PubMed ID: 35044623
[TBL] [Abstract][Full Text] [Related]
2. Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease.
Löhle M; Mangone G; Wolz M; Beuthien-Baumann B; Oehme L; van den Hoff J; Kotzerke J; Reichmann H; Corvol JC; Storch A
Mov Disord; 2018 Sep; 33(9):1496-1501. PubMed ID: 30216543
[TBL] [Abstract][Full Text] [Related]
3. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
Kumudini N; Umai A; Devi YP; Naushad SM; Mridula R; Borgohain R; Kutala VK
Indian J Biochem Biophys; 2013 Oct; 50(5):436-41. PubMed ID: 24772965
[TBL] [Abstract][Full Text] [Related]
4. Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.
Devos D; Lejeune S; Cormier-Dequaire F; Tahiri K; Charbonnier-Beaupel F; Rouaix N; Duhamel A; Sablonnière B; Bonnet AM; Bonnet C; Zahr N; Costentin J; Vidailhet M; Corvol JC
Parkinsonism Relat Disord; 2014 Feb; 20(2):170-5. PubMed ID: 24216088
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele.
Planté-Bordeneuve V; Taussig D; Thomas F; Said G; Wood NW; Marsden CD; Harding AE
Neurology; 1997 Jun; 48(6):1589-93. PubMed ID: 9191771
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.
Masellis M; Collinson S; Freeman N; Tampakeras M; Levy J; Tchelet A; Eyal E; Berkovich E; Eliaz RE; Abler V; Grossman I; Fitzer-Attas C; Tiwari A; Hayden MR; Kennedy JL; Lang AE; Knight J;
Brain; 2016 Jul; 139(Pt 7):2050-62. PubMed ID: 27190009
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
Moreau C; Meguig S; Corvol JC; Labreuche J; Vasseur F; Duhamel A; Delval A; Bardyn T; Devedjian JC; Rouaix N; Petyt G; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Azulay JP; Tison F; Destée A; Vidailhet M; Rascol O; Dujardin K; Defebvre L; Bordet R; Sablonnière B; Devos D;
Brain; 2015 May; 138(Pt 5):1271-83. PubMed ID: 25805645
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
BMC Neurol; 2011 Jul; 11():89. PubMed ID: 21781348
[TBL] [Abstract][Full Text] [Related]
9. Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease.
Eryilmaz IE; Erer S; Zarifoglu M; Egeli U; Karakus E; Yurdacan B; Cecener G; Tunca B; Colakoglu B; Bora Tokcaer A; Saka E; Demirkiran M; Akbostanci C; Dogu O; Kaleagasi H; Kenangil G; Cakmur R; Elibol B
Clin Neurol Neurosurg; 2020 Dec; 199():106257. PubMed ID: 33039854
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism.
Costa-Mallen P; Costa LG; Smith-Weller T; Franklin GM; Swanson PD; Checkoway H
J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):535-7. PubMed ID: 10990520
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease.
Bäckström D; Eriksson Domellöf M; Granåsen G; Linder J; Mayans S; Elgh E; Zetterberg H; Blennow K; Forsgren L
Acta Neurol Scand; 2018 Jan; 137(1):91-98. PubMed ID: 28869277
[TBL] [Abstract][Full Text] [Related]
12. MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
Sampaio TF; Dos Santos EUD; de Lima GDC; Dos Anjos RSG; da Silva RC; Asano AGC; Asano NMJ; Crovella S; de Souza PRE
J Clin Pharmacol; 2018 Jul; 58(7):920-926. PubMed ID: 29578580
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease.
Li L; Lin H; Hua P; Yan L; Dong H; Li T; Liu W
Front Neurol; 2020; 11():520934. PubMed ID: 33250838
[TBL] [Abstract][Full Text] [Related]
14. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.
Torkaman-Boutorabi A; Ali Shahidi G; Choopani S; Reza Zarrindast M
Folia Neuropathol; 2012; 50(4):382-9. PubMed ID: 23319194
[TBL] [Abstract][Full Text] [Related]
15. Association of the DRD2 CA
Xu S; Liu J; Yang X; Qian Y; Xiao Q
J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
[TBL] [Abstract][Full Text] [Related]
16. Variability and validity of polymorphism association studies in Parkinson's disease.
Tan EK; Khajavi M; Thornby JI; Nagamitsu S; Jankovic J; Ashizawa T
Neurology; 2000 Aug; 55(4):533-8. PubMed ID: 10953187
[TBL] [Abstract][Full Text] [Related]
17. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.
Kwak Y; Bohnen NI; Müller ML; Dayalu P; Burke DT; Seidler RD
Behav Brain Res; 2013 May; 245():128-36. PubMed ID: 23439215
[TBL] [Abstract][Full Text] [Related]
18. The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.
Oliveri RL; Annesi G; Zappia M; Civitelli D; De Marco EV; Pasqua AA; Annesi F; Spadafora P; Gambardella A; Nicoletti G; Branca D; Caracciolo M; Aguglia U; Quattrone A
Mov Disord; 2000 Jan; 15(1):127-31. PubMed ID: 10634251
[TBL] [Abstract][Full Text] [Related]
19. DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients.
Zainal Abidin S; Tan EL; Chan SC; Jaafar A; Lee AX; Abd Hamid MH; Abdul Murad NA; Pakarul Razy NF; Azmin S; Ahmad Annuar A; Lim SY; Cheah PS; Ling KH; Mohamed Ibrahim N
BMC Neurol; 2015 Apr; 15():59. PubMed ID: 25896831
[TBL] [Abstract][Full Text] [Related]
20. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.
Mellick GD; Buchanan DD; McCann SJ; James KM; Johnson AG; Davis DR; Liyou N; Chan D; Le Couteur DG
Mov Disord; 1999 Mar; 14(2):219-24. PubMed ID: 10091612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
